US › Healthcare

OrganiGram Holdings Inc (OGI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.07+0.94%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$105.8M

Revenue YoY

+49.4%

Net profit

$105.5M

EPS

$-0.05

EPS estimate

$-0.01

Net margin

99.8%

EPS came in at -0.05 against a street estimate of -0.01 — a miss of 400.0%.

Key statistics

Market cap

$149.5M

P/E

2.4

Forward P/E

14.6

P/B

0.43

Book value

$2.60

EPS (TTM)

$0.44

52-week high

$2.24

52-week low

$0.85

50-day MA

$1.07

200-day MA

$1.32

Beta

1.91

Analyst view

Analysts rate OrganiGram Holdings Inc a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $8.80.

Shareholding

Insiders

31.06%

Institutions

6.56%

Largest institutional holders

Fund	Stake
Tidal Investments LLC.	1.54%
Renaissance Technologies Corp	1.16%
AdvisorShares Investments, LLC	0.63%
The Goldman Sachs Group Inc	0.41%
Morgan Stanley - Brokerage Accounts	0.26%
Baader Bank INC	0.18%
Bank of Montreal	0.17%
BMO Capital Markets Corp.	0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OrganiGram Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.